Correction : Clinical Epigenetics (2022) 14:191 https://doi.org/10.1186/s13148-022-01418-0
Following publication of the original article [1], the authors have realized that ethics statement and Acknowledgement Section are incomplete. The corrected ethics statement should read as follows:
The prospective nested case–control study was approved by the Ethics Committee of Nanjing Medical University (No. 2015077). For Hospital-based case–control studies were approved by the ethics committee of Affiliated Hospital of Xuzhou Medical University (No. XYFY2018-KL078), Affiliated Jiangning Hospital of Nanjing Medical University (No.2018676), Jurong People's Hospital (No.JRSRMYY-2019-02), All the recruited participants were Chinese Han and provided written informed consent.
In full Acknowledgement statement should state:
We would like to thank Yu Liu, Min Liu and Haifeng Xu for their contribution to the study. We would also thank to Dr. Deqin Geng and Dr. Lihua Liu for their contribution in allowing blood samples and related information collection. We would also like to express our gratitude to all of the participants of the contributing studies to each of these datasets.
Reference
Liu C, Li M, Yin Q, et al. HTRA1 methylation in peripheral blood as a potential marker for the preclinical detection of stroke: a case–control study and a prospective nested case–control study. Clin Epigenet. 2022;14:191. https://doi.org/10.1186/s13148-022-01418-0.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Liu, C., Li, M., Yin, Q. et al. Correction : HTRA1 methylation in peripheral blood as a potential marker for the preclinical detection of stroke: a case–control study and a prospective nested case–control study. Clin Epigenet 15, 141 (2023). https://doi.org/10.1186/s13148-023-01558-x
Published:
DOI: https://doi.org/10.1186/s13148-023-01558-x